20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-κB activation and the production of inflammatory cytokines in human endothelial cells

Tsuneo Ishizuka, Jennifer Cheng, Harpreet Singh, Marco D. Vitto, Vijay L. Manthati, J R Falck, Michal Laniado-Schwartzman

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Endothelial dysfunction is associated with endothelial cell activation, i.e., up-regulation of surface cell adhesion molecules and the release of proinflammatory cytokines. 20-Hydroxyeicosatetraenoic acid (HETE), a major vasoactive eicosanoid in the microcirculation, has been implicated in the regulation of endothelial cell function through its angiogenic and pro-oxidative properties. We examined the effects of 20-HETE on endothelial cell activation in vitro. Cells transduced with adenovirus containing either CYP4A1 or CYP4A2 produced higher levels of 20-HETE, and they demonstrated increased expression levels of the adhesion molecule intercellular adhesion molecule (ICAM) (4-7-fold) and the oxidative stress marker 3-nitrotyrosine (2-3-fold) compared with cells transduced with control adenovirus. Treatment of cells with 20-HETE markedly increased levels of prostaglandin (PG) E2 and 8-epi-isoprostane PGF, commonly used markers of activation and oxidative stress, and most prominently, interleukin-8, a potent neutrophil chemotactic factor whose overproduction by the endothelium is a key feature of vascular injury. 20-HETE at nanomolar concentrations increased inhibitor of nuclear factor-κB phosphorylation by 2 to 5-fold within 5 min, which was followed with increased nuclear translocation of nuclear factor-κB (NF-κB). Likewise, 20-HETE activated the mitogen-activated protein kinase/ extracellular signal-regulated kinase (MAPK/ERK) pathway by stimulating phosphorylation of ERK1/2. Inhibition of NF-κB activation and inhibition of ERK1/2 phosphorylation inhibited 20-HETE-induced ICAM expression. It seems that 20-HETE triggers NF-κB and MAPK/ERK activation and that both signaling pathways participate in the cellular mechanisms by which 20-HETE activates vascular endothelial cells.

Original languageEnglish (US)
Pages (from-to)103-110
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume324
Issue number1
DOIs
StatePublished - Jan 2008

Fingerprint

Endothelial Cells
Cytokines
Cell Adhesion Molecules
8-epi-prostaglandin F2alpha
Extracellular Signal-Regulated MAP Kinases
Phosphorylation
Mitogen-Activated Protein Kinases
Interleukin-8
Adenoviridae
Oxidative Stress
20-hydroxy-5,8,11,14-eicosatetraenoic acid
Dinoprost
Eicosanoids
Vascular System Injuries
Microcirculation
Dinoprostone
Endothelium
Up-Regulation

ASJC Scopus subject areas

  • Pharmacology

Cite this

20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-κB activation and the production of inflammatory cytokines in human endothelial cells. / Ishizuka, Tsuneo; Cheng, Jennifer; Singh, Harpreet; Vitto, Marco D.; Manthati, Vijay L.; Falck, J R; Laniado-Schwartzman, Michal.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 324, No. 1, 01.2008, p. 103-110.

Research output: Contribution to journalArticle

Ishizuka, Tsuneo ; Cheng, Jennifer ; Singh, Harpreet ; Vitto, Marco D. ; Manthati, Vijay L. ; Falck, J R ; Laniado-Schwartzman, Michal. / 20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-κB activation and the production of inflammatory cytokines in human endothelial cells. In: Journal of Pharmacology and Experimental Therapeutics. 2008 ; Vol. 324, No. 1. pp. 103-110.
@article{b5b178740d4242f08444598d8b7a03c8,
title = "20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-κB activation and the production of inflammatory cytokines in human endothelial cells",
abstract = "Endothelial dysfunction is associated with endothelial cell activation, i.e., up-regulation of surface cell adhesion molecules and the release of proinflammatory cytokines. 20-Hydroxyeicosatetraenoic acid (HETE), a major vasoactive eicosanoid in the microcirculation, has been implicated in the regulation of endothelial cell function through its angiogenic and pro-oxidative properties. We examined the effects of 20-HETE on endothelial cell activation in vitro. Cells transduced with adenovirus containing either CYP4A1 or CYP4A2 produced higher levels of 20-HETE, and they demonstrated increased expression levels of the adhesion molecule intercellular adhesion molecule (ICAM) (4-7-fold) and the oxidative stress marker 3-nitrotyrosine (2-3-fold) compared with cells transduced with control adenovirus. Treatment of cells with 20-HETE markedly increased levels of prostaglandin (PG) E2 and 8-epi-isoprostane PGF2α, commonly used markers of activation and oxidative stress, and most prominently, interleukin-8, a potent neutrophil chemotactic factor whose overproduction by the endothelium is a key feature of vascular injury. 20-HETE at nanomolar concentrations increased inhibitor of nuclear factor-κB phosphorylation by 2 to 5-fold within 5 min, which was followed with increased nuclear translocation of nuclear factor-κB (NF-κB). Likewise, 20-HETE activated the mitogen-activated protein kinase/ extracellular signal-regulated kinase (MAPK/ERK) pathway by stimulating phosphorylation of ERK1/2. Inhibition of NF-κB activation and inhibition of ERK1/2 phosphorylation inhibited 20-HETE-induced ICAM expression. It seems that 20-HETE triggers NF-κB and MAPK/ERK activation and that both signaling pathways participate in the cellular mechanisms by which 20-HETE activates vascular endothelial cells.",
author = "Tsuneo Ishizuka and Jennifer Cheng and Harpreet Singh and Vitto, {Marco D.} and Manthati, {Vijay L.} and Falck, {J R} and Michal Laniado-Schwartzman",
year = "2008",
month = "1",
doi = "10.1124/jpet.107.130336",
language = "English (US)",
volume = "324",
pages = "103--110",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - 20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-κB activation and the production of inflammatory cytokines in human endothelial cells

AU - Ishizuka, Tsuneo

AU - Cheng, Jennifer

AU - Singh, Harpreet

AU - Vitto, Marco D.

AU - Manthati, Vijay L.

AU - Falck, J R

AU - Laniado-Schwartzman, Michal

PY - 2008/1

Y1 - 2008/1

N2 - Endothelial dysfunction is associated with endothelial cell activation, i.e., up-regulation of surface cell adhesion molecules and the release of proinflammatory cytokines. 20-Hydroxyeicosatetraenoic acid (HETE), a major vasoactive eicosanoid in the microcirculation, has been implicated in the regulation of endothelial cell function through its angiogenic and pro-oxidative properties. We examined the effects of 20-HETE on endothelial cell activation in vitro. Cells transduced with adenovirus containing either CYP4A1 or CYP4A2 produced higher levels of 20-HETE, and they demonstrated increased expression levels of the adhesion molecule intercellular adhesion molecule (ICAM) (4-7-fold) and the oxidative stress marker 3-nitrotyrosine (2-3-fold) compared with cells transduced with control adenovirus. Treatment of cells with 20-HETE markedly increased levels of prostaglandin (PG) E2 and 8-epi-isoprostane PGF2α, commonly used markers of activation and oxidative stress, and most prominently, interleukin-8, a potent neutrophil chemotactic factor whose overproduction by the endothelium is a key feature of vascular injury. 20-HETE at nanomolar concentrations increased inhibitor of nuclear factor-κB phosphorylation by 2 to 5-fold within 5 min, which was followed with increased nuclear translocation of nuclear factor-κB (NF-κB). Likewise, 20-HETE activated the mitogen-activated protein kinase/ extracellular signal-regulated kinase (MAPK/ERK) pathway by stimulating phosphorylation of ERK1/2. Inhibition of NF-κB activation and inhibition of ERK1/2 phosphorylation inhibited 20-HETE-induced ICAM expression. It seems that 20-HETE triggers NF-κB and MAPK/ERK activation and that both signaling pathways participate in the cellular mechanisms by which 20-HETE activates vascular endothelial cells.

AB - Endothelial dysfunction is associated with endothelial cell activation, i.e., up-regulation of surface cell adhesion molecules and the release of proinflammatory cytokines. 20-Hydroxyeicosatetraenoic acid (HETE), a major vasoactive eicosanoid in the microcirculation, has been implicated in the regulation of endothelial cell function through its angiogenic and pro-oxidative properties. We examined the effects of 20-HETE on endothelial cell activation in vitro. Cells transduced with adenovirus containing either CYP4A1 or CYP4A2 produced higher levels of 20-HETE, and they demonstrated increased expression levels of the adhesion molecule intercellular adhesion molecule (ICAM) (4-7-fold) and the oxidative stress marker 3-nitrotyrosine (2-3-fold) compared with cells transduced with control adenovirus. Treatment of cells with 20-HETE markedly increased levels of prostaglandin (PG) E2 and 8-epi-isoprostane PGF2α, commonly used markers of activation and oxidative stress, and most prominently, interleukin-8, a potent neutrophil chemotactic factor whose overproduction by the endothelium is a key feature of vascular injury. 20-HETE at nanomolar concentrations increased inhibitor of nuclear factor-κB phosphorylation by 2 to 5-fold within 5 min, which was followed with increased nuclear translocation of nuclear factor-κB (NF-κB). Likewise, 20-HETE activated the mitogen-activated protein kinase/ extracellular signal-regulated kinase (MAPK/ERK) pathway by stimulating phosphorylation of ERK1/2. Inhibition of NF-κB activation and inhibition of ERK1/2 phosphorylation inhibited 20-HETE-induced ICAM expression. It seems that 20-HETE triggers NF-κB and MAPK/ERK activation and that both signaling pathways participate in the cellular mechanisms by which 20-HETE activates vascular endothelial cells.

UR - http://www.scopus.com/inward/record.url?scp=37349011542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37349011542&partnerID=8YFLogxK

U2 - 10.1124/jpet.107.130336

DO - 10.1124/jpet.107.130336

M3 - Article

C2 - 17947496

AN - SCOPUS:37349011542

VL - 324

SP - 103

EP - 110

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -